News: Long Island

Attivissimo of Greiner-Maltz completes $4.5 million transaction

A manufacturer of high quality door hardware is thriving, and expanding. On the heels of signing a deal in London for an additional retail location the Nanz Company relocated its manufacturing facility from Brooklyn to Deer Park, Long Island. Tom Attivissimo, CCIM and senior managing director of Greiner Maltz of Long Island who transacted the deal for Nanz said, "Companies lose about 10% of floor space on each floor in loft buildings, so moving from a three story 25,000 s/f to a one story 40,000 s/f facility is over 100% expansion. This move allows Nanz to compete and be profitable with the help of the Town of Babylon Economic Development benefits and the employee training programs at Suffolk Community College. The Town of Babylon's incentives for manufacturing attracted Nanz from Brooklyn to come to 105 East Industry Court. Thanks to the economic development team at the Town of Babylon headed by Bob Strickoff and John Lomabardo director of education at SCC, Nanz was able to overcome tremendous hurdles that are inherent in manufacturing on Long Island. A company like Nanz from outside the Long Island market would find it very difficult to successfully marshal a transaction of this magnitude in short order if it were nor for precise coordination of many complex variables. "Orchestration is the key." said Attivissimo. If not for precise orchestration the transaction collapses and 200 hundred employees stay in Brooklyn and Nanz settles for mediocrity instead of bringing the company to a new level of growth. Attivissimo had help in orchestrating the Nanz deal with the IDA expertise of the Law Office of Mark Cuthbertson. Attivissimo acknowledges this deal may not have happened without Cuthbertson's help. The total transaction with machinery, renovations and building, was over $4.5 million.
MORE FROM Long Island

Suffolk County IDA supports expansion of A&Z Pharmaceuticals

Hauppauge, NY The Suffolk County Industrial Development Agency (IDA) has granted preliminary approval of a financial incentive package that will assist a manufacturer in expanding its business by manufacturing more prescription (Rx) pharmaceuticals in addition to its existing over-the-counter
READ ON THE GO
DIGITAL EDITIONS
Subscribe